Genentech Patient Foundation
The Genentech Patient Foundation by Roche provides free Genentech medicines to uninsured or underinsured US patients, supporting equitable access to advanced therapies.
Funder: Roche
Due Dates: Rolling (Applications accepted year-round)
Funding Amounts: Free Genentech medicines for eligible patients; no direct monetary award; support continues as long as eligibility is maintained.
Summary: Provides access to Genentech medicines at no cost for U.S.-based patients facing financial hardship or inadequate insurance coverage.
Key Information: Patients required by their insurer/employer to apply to the Foundation as a prerequisite for coverage are not eligible.
Description
The Genentech Patient Foundation, supported by Roche, ensures that eligible patients in the United States who are uninsured or underinsured can access Genentech medicines at no cost. The program is designed to remove financial barriers for patients who have been prescribed a Genentech medication but are unable to afford it due to lack of insurance coverage or high out-of-pocket costs. The Foundation offers comprehensive support, including assistance with the application process, and provides free medicines directly to patients, their healthcare providers, or treatment centers.
